Insertion and Orientation of a Synthetic Peptide Representing the C-Terminus of the A1Domain of Shiga Toxin into Phospholipid Membranes†

Biochemistry ◽  
1996 ◽  
Vol 35 (29) ◽  
pp. 9325-9334 ◽  
Author(s):  
Mazen T. Saleh ◽  
Jim Ferguson ◽  
Joan M. Boggs ◽  
Jean Gariépy
Biochemistry ◽  
1997 ◽  
Vol 36 (50) ◽  
pp. 15865-15872 ◽  
Author(s):  
Abdellah Menikh ◽  
Mazen T. Saleh ◽  
Jean Gariépy ◽  
Joan M. Boggs

2009 ◽  
Vol 284 (10) ◽  
pp. 6194-6199 ◽  
Author(s):  
Julia H. Appleby ◽  
Kaisong Zhou ◽  
Gerrit Volkmann ◽  
Xiang-Qin Liu

1998 ◽  
Vol 18 (6) ◽  
pp. 299-312 ◽  
Author(s):  
Parvez I. Haris

Potassium channels are a diverse class of transmembrane proteins that are responsible for diffusion of potassium ion across cell membranes. The lack of large quantities of these proteins from natural sources, is a major hindrance in their structural characterization using biophysical techniques. Synthetic peptide fragments corresponding to functionally important domains of these proteins provide an attractive approach towards characterizing the structural organization of these ion-channels. Conformational properties of peptides from three different potassium channels (Shaker, ROMK1 and minK) have been characterized in aqueous media, organic solvents and in phospholipid membranes. Techniques used for these studies include FTIR, CD and 2D-NMR spectroscopy. FTIR spectroscopy has been a particularly valuable tool for characterizing the folding of the ion-channel peptides in phospholipid membranes; the three different types of potassium channels all share a common transmembrane folding pattern that is composed of a predominantly α-helical structure. There is no evidence to suggest the presence of any significant β-sheet structure. These results are in excellent agreement with the crystal structure of a bacterial potassium channel (Doyle, D. A. et al. (1998) Science280:69–77), and suggest that all potassium channel proteins may share a common folding motif where the ion-channel structure is constructed entirely from α-helices.


1987 ◽  
Author(s):  
U Scheefers-Borchel ◽  
G Muller-Berghaus

To determine soluble fibrin in blood of patients with coagulation disorders we produced monoclonal antibodies which distinct fibrin from fibrinogen and other blood constituents. Fibrin-specific monoclonal antibodies were obtained by immunizing mice with the synthetic hexapeptide Leu-Ile-Asp-Gly-Lys-Met which was covalently linked to KLH via its C-terminus. Several of the monoclonal antibodies which reacted with the hexapeptide also reacted with batroxobin-induced desAA-fibrin and thrombin-induced desAABB-fibrin, but not with fibrinogen. No reaction was observed with plasmin-induced fibrinogenolytic and fibrinolytic degradation products, respectively. The epitope recognized by these fibrin-specific antibodies is located on the αchain of fibrin and is not accessible for an antibody in native fibrinogen. One monoclonal antibody (B/H11) was used to quantify the amount of soluble fibrin in plasma of patients with a variety of coagulation disorders. This antibody could also be used to develop an ELISA based on two different fibrin-specific monoclonal antibodies. For this assay anti-fbn 17 (Scheefers- Borchel et al., Proc. Natl. Acad. Sci. USA 82: 7091, 1985) was coated onto ELISA plates. After adding plasma which contained soluble fibrin, the fibrin bound was detected by the second fibrin-specific antibody B/H^ to which biotin was covalently linked. The second antibody was probed by the addition of peroxydase conjugated streptavidin and the substrate ABTS for peroxydase. This test can be used to detect fibrin at concentrations as low as 70 ng/ml. With this assay system, it is possible to measure the amount of soluble fibrin present in plasma samples without the interference of fibrinogen which is associated with soluble fibrin.


Virology ◽  
1986 ◽  
Vol 155 (2) ◽  
pp. 625-632 ◽  
Author(s):  
David C. Jackson ◽  
Xi-Lin Tang ◽  
Lorena E. Brown ◽  
Julie M. Murray ◽  
David O. White ◽  
...  

1990 ◽  
Vol 97 (4) ◽  
pp. 607-614
Author(s):  
B. Geiger ◽  
T. Volberg ◽  
D. Ginsberg ◽  
S. Bitzur ◽  
I. Sabanay ◽  
...  

We describe here the preparation and application of antibodies directed against a synthetic, 24 amino acid long, peptide corresponding to the conserved cytoplasmic C terminus of N-cadherin. We demonstrate here that the antibodies to the synthetic peptide react extensively with all known members of the cadherin family and, in addition, recognize novel cadherins in a variety of cells and tissues, suggesting that these antibodies indeed exhibit pan-cadherin reactivity. By Western blot screening of chicken tissues at least 4 different immunoreactive bands were resolved, commonly disclosing 2–3 distinct bands within the same tissue. The pan-cadherin antibodies also displayed a broad interspecies cross reactivity, recognizing cadherins in man, bovine, canine, avian, amphibian and teleost cells. This property renders these antibodies excellent reagents for the cloning and identification of novel cadherins. Immunocytochemical labelling with the pan-cadherin antibodies, at the light- and electron-microscope levels, revealed an extensive reactivity with intercellular adherens junctions in cardiac muscle and in various epithelia. We thus propose that the pan-cadherin antibodies may be used as ubiquitous cadherin probes and serve as markers for adherens junctions.


Sign in / Sign up

Export Citation Format

Share Document